Stalder., Helv. Chim. Acta., vol. 69, 1986 pp. 1887-1897. |
Disposition of anagrelide, an inhibitor of platelet aggregation; Clinical Pharmacology and Therapeutics; Gaver et al.; vol. 29; 1981; pp. 381-386. |
Focus on Anagrelide; Drugs, May 1994; vol. 5; pp. 809-822; Issn: 0012-6667. |
Analysis of the Mechanism of Anagrelide-Induced Thrombocytopenia in Humans; Eric M. Mazur et al.; Blood; vol. 79; No. 8; Apr. 15, 1992; pp. 1931-1937. |
Agrylin (anagrelide hydrochloride); Product Monograph; Roberts Pharmaceuticals Corp.; 1997. |
Anagrelide for Control of Thrombocythemia in Polycythemia and Other Myeloproliferative Disorders; Petitt et al.; Seminars in Hematology; vol. 34; No. 1, (Jan.); 1997; pp. 51-54. |
Anagrelide, a selective thrombocytopenic agent, American Journal of Health-System Pharmacy, vol. 55, Oct. 1, 1998; pp. 1979-1986. |
Blood; Journal of the American Society of Hematology; W. R. Saunders Company; vol. 94; No. 10; Supplement 1 (Part 1 of 2); Nov. 15, 1999; p. 701a. |